Astrazeneca Share Discussion Threads

[essentialinvestor] 12/11/2021 14:52

In for just a small amount.

[montyhedge] 12/11/2021 14:40

They can't justify this high rating on these figures.

[cgee1] 12/11/2021 14:35

Just goes to show what little knowledge you have of the pharmaceutical industry if you think it's easy getting a drug onto the market..... But hey John I guess when you get something wrong with you you won't be asking for any tablets because they are made by those big bad pharma companiesYour other post says it all really what a prat.... Of course Google are on board covering the pandemic scam up! .... I think your Google search results are more down to what you look at and ask Google to find.... Try typing Brianne Dressen and you'll get lots of hits but of course it's a cover up by GoogleTry not surfing the porn so much dear John and your search results might be a bit more relevantNot reading anymore of your drivel...Filtered

[philanderer] 12/11/2021 14:12

Jeez, I'm going to hell in a handcart.

I hold AZN, GSK, IMB and BATS !

[philanderer] 12/11/2021 14:01

FWIW

12th nov UBS buy tp 10000p
12th nov Jefferies buy tp 9950p
12th nov JP Morgan overweight tp 10000p


Sharecast:

IG market analyst Joshua Mahony said: "AstraZeneca has seen little enthusiasm for their plan to shift into a strategy of ‘modest profitability’ for their vaccine product, with the company hoping to strike new deals at a more advantageous price.

"Coming off the back of a nine-month period that brought $2.2 billion of vaccine sales, shareholders are clearly looking for the firm to boost the earnings outlook after EPS fell short of expectations."

[bountyhunter] 12/11/2021 13:56

Too much googling by the sound of it. Probably on 10p a post from the expensive for profit competition. Filtered.

[holts] 12/11/2021 13:47

@john ,

Have you been allowed out for the day ?

[the lockkeeper] 12/11/2021 13:19

cgee its his opinion so it must be right! ;)

[bountyhunter] 12/11/2021 13:08

More to the point how many hundred thousand lives has the at cost Astra vaccine saved? Without it the world would be in a much worse state. It's sad to see AZN talked down when it's been the only pharma to prove a charitable at cost global response to the pandemic.

[cgee1] 12/11/2021 12:31

Where's your proof then John?

[john nada] 12/11/2021 12:06

Immoral POS.

[john nada] 12/11/2021 11:23

If you invest in this company you're going to hell in all likelihood. Deleting those trial participants who develop severe reactions and completely denying it is criminal behaviour. People will pay and pay big.

[philanderer] 12/11/2021 11:04

Oh well ...

"..In equity markets, AstraZeneca fell after its quarterly profit missed expectations but the company said it would start making a profit from its Covid vaccine from the fourth quarter onwards."

ADVFN market open

[bountyhunter] 12/11/2021 09:02

AstraZeneca revenue gets Covid booster

great headline :)

[bountyhunter] 12/11/2021 08:55

Profit margins down but profits still up 14% YoY which sounds pretty good to me.

The pipeline and forecast revenue growth are excellent

Guidance

The Company provides further details on its FY 2021 guidance at CER.

Total revenue excluding the COVID-19 vaccine is expected to grow by a low-twenties percentage, in line with prior guidance. Including vaccine revenues in Q4 2021, revenue is expected to grow by a mid-to-high twenties percentage.
I thought Monty shorted just about everything hence his outlook.

[porsche1945] 12/11/2021 08:37

Selling a lot of stuff but poor quality profits….

If Monty is invested in this you are all fxxked, he only buys U.K. dividend sxxt that halves in value every ten years….

[bountyhunter] 12/11/2021 08:14

No not at all, everything is on track, there will even likely be an increasing contribution on top of this from the vaccine revenue as we emerge from the pandemic as indicated above.


Pascal Soriot, Chief Executive Officer, commented:

"AstraZeneca's scientific leadership continues to provide strong revenue growth and exceptional pipeline delivery, with eight positive late-stage readouts across seven medicines since June, including our long acting antibody combination showing promise in both prevention and treatment of COVID-19. The addition of Alexion furthers our commitment to bring transformative therapies to patients around the world, and I am proud of our colleagues' ongoing dedication and focus.

Our broad portfolio of medicines and diversified geographic exposure provides a robust platform for long-term sustainable growth. Following accelerated investment in upcoming launches after positive data flow, we expect a solid finish to the year and our earnings guidance is unchanged."

[montyhedge] 12/11/2021 08:07

Disappointing.

[bountyhunter] 12/11/2021 07:51

Great minds think alike - I was about to post exactly the same section and had it in the clipboard before reading your post, which just goes to show the significance! ☺️

[p1es] 12/11/2021 07:16

"Prior guidance excluded the revenue and profit impact of sales of the pandemic vaccine. The Company is now expecting to progressively transition the vaccine to modest profitability as new orders are received."

[bountyhunter] 11/11/2021 14:50

Back in here...
Q3 Results 12-Nov-2021
I'm expecting strong results and prospects tomorrow following on from GSK's which spurred a decent rise there only a couple of weeks ago. A hundred quid a share would do nicely ;-)

[beckers2008] 10/11/2021 10:28

ASTRAZENECA : Receives a Buy rating from Barclays.

Already positive, the research from Barclays and its analyst Emily Field still consider the stock as a Buy opportunity. The target price has been revised upwards and is now set at GBX 11000, compared with GBX 10000 previously.